| Product Code: ETC9475752 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sri Lanka Personalized Cancer Vaccines Market Overview |
3.1 Sri Lanka Country Macro Economic Indicators |
3.2 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Sri Lanka Personalized Cancer Vaccines Market - Industry Life Cycle |
3.4 Sri Lanka Personalized Cancer Vaccines Market - Porter's Five Forces |
3.5 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume Share, By Mechanism of Action Type, 2021 & 2031F |
3.7 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume Share, By Bio-Maker Type, 2021 & 2031F |
3.9 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.10 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Sri Lanka Personalized Cancer Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Sri Lanka |
4.2.2 Growing awareness about personalized medicine and vaccines |
4.2.3 Advancements in healthcare technology and research |
4.3 Market Restraints |
4.3.1 High cost associated with personalized cancer vaccines |
4.3.2 Limited accessibility to advanced healthcare facilities in certain regions of Sri Lanka |
4.3.3 Regulatory challenges and approval processes for personalized vaccines |
5 Sri Lanka Personalized Cancer Vaccines Market Trends |
6 Sri Lanka Personalized Cancer Vaccines Market, By Types |
6.1 Sri Lanka Personalized Cancer Vaccines Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.4 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.5 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Leukaemia, 2021- 2031F |
6.1.7 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.8 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2 Sri Lanka Personalized Cancer Vaccines Market, By Mechanism of Action Type |
6.2.1 Overview and Analysis |
6.2.2 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Tumour-associated Antigens (TAAs), 2021- 2031F |
6.2.3 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Tumour-specific Antigens (TSAs), 2021- 2031F |
6.2.4 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Somatic Mutations in Cancer Pharmacogenomics, 2021- 2031F |
6.2.5 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Pharmacogenomics towards Genomic Polymorphism, 2021- 2031F |
6.3 Sri Lanka Personalized Cancer Vaccines Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Dendritic Cells (DC) Cancer Vaccines, 2021- 2031F |
6.3.3 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Recombinant Cancer Vaccines, 2021- 2031F |
6.3.4 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Antigen/Adjuvant Cancer Vaccines, 2021- 2031F |
6.3.5 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Viral Vector and DNA Cancer Vaccines, 2021- 2031F |
6.4 Sri Lanka Personalized Cancer Vaccines Market, By Bio-Maker Type |
6.4.1 Overview and Analysis |
6.4.2 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.4.3 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Prognostic and Predictive Biomarkers, 2021- 2031F |
6.4.4 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Immune Checkpoint Biomarkers, 2021- 2031F |
6.4.5 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sri Lanka Personalized Cancer Vaccines Market, By Treatment Type |
6.5.1 Overview and Analysis |
6.5.2 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Preventive Cancer Vaccines, 2021- 2031F |
6.5.3 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Therapeutic Cancer Vaccines, 2021- 2031F |
6.6 Sri Lanka Personalized Cancer Vaccines Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Injectables, 2021- 2031F |
6.6.3 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Sri Lanka Personalized Cancer Vaccines Market, By End Users |
6.7.1 Overview and Analysis |
6.7.2 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.7.4 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Sri Lanka Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Sri Lanka Personalized Cancer Vaccines Market Import-Export Trade Statistics |
7.1 Sri Lanka Personalized Cancer Vaccines Market Export to Major Countries |
7.2 Sri Lanka Personalized Cancer Vaccines Market Imports from Major Countries |
8 Sri Lanka Personalized Cancer Vaccines Market Key Performance Indicators |
8.1 Percentage increase in adoption of personalized cancer vaccines in Sri Lanka |
8.2 Number of clinical trials and research studies conducted on personalized cancer vaccines |
8.3 Rate of approval for personalized cancer vaccines by regulatory authorities in Sri Lanka |
9 Sri Lanka Personalized Cancer Vaccines Market - Opportunity Assessment |
9.1 Sri Lanka Personalized Cancer Vaccines Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Sri Lanka Personalized Cancer Vaccines Market Opportunity Assessment, By Mechanism of Action Type, 2021 & 2031F |
9.3 Sri Lanka Personalized Cancer Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Sri Lanka Personalized Cancer Vaccines Market Opportunity Assessment, By Bio-Maker Type, 2021 & 2031F |
9.5 Sri Lanka Personalized Cancer Vaccines Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.6 Sri Lanka Personalized Cancer Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Sri Lanka Personalized Cancer Vaccines Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Sri Lanka Personalized Cancer Vaccines Market - Competitive Landscape |
10.1 Sri Lanka Personalized Cancer Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Sri Lanka Personalized Cancer Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here